The new 2019 KDOQI Guidelines were recently released and Transonic applauds the committee for its diligence and guidance that every hemodialysis treatment option be customized to the individual hemodialysis patient.
As a long-time vascular access flow measurement surveillance provider and expert on vascular access flow, the dialysis community has often reached out to Transonic for feedback on vascular access surveillance and flow. Before our entrance into the Hemodialysis market, Transonic had already earned a reputation as the gold standard measurement for highly accurate tubing flow measurements and blood vessel flow measurements during surgical procedures.
Transonic was then asked by leading nephrologists such as Dr. Thomas Depner to provide quantitative access flow data to support a nephrologist’s clinical decision making. In a brilliant moment of inspiration, Transonic’s Dr. Nikolai Krivitski envisioned a method of combining transit-time ultrasound flow technology and indicator dilution technology to enable a novel, non-invasive flow measurement of the actual volume flow in mLs/min that is flowing through the vascular access itself. This measurement, trended over time, allowed nephrologists their first inside peek ever into what the true flow was within an access. By giving hemodialysis staff an actual measure of vascular access flow, this new tool revolutionized hemodialysis. However, how this novel measurement should be integrated into a hemodialysis protocol was and continues to be a topic of discussion and debate, as evidenced in the recent KDOQI revisions.